WallStSmart
EXAS

EXACT Sciences Corporation

NASDAQ: EXAS · HEALTHCARE · DIAGNOSTICS & RESEARCH

$104.91
+0.00% today

Updated 2026-03-24

Market cap
$20.03B
P/E ratio
P/S ratio
6.17x
EPS (TTM)
$-1.10
Dividend yield
52W range
$39 – $1,878
Volume
2.7M

EXACT Sciences Corporation (EXAS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-12.15M$-8.77M$-7.90M$-12.64M$-13.48M$-27.82M$-44.16M$-39.30M$-80.91M$-134.02M$-130.07M$-71.72M$-69.33M$-111.66M$136.48M$-102.24M$-223.56M$156.12M$210.54M$491.44M
Capital expenditures$394000.00$132000.00$104000.00$462000.00$626000.00$2.12M$681000.00$9.28M$12.54M$21.98M$14.85M$69.24M$150.67M$172.65M$64.35M$135.77M$214.46M$124.19M$135.99M$134.66M
Depreciation
Stock-based comp$3.01M$2.81M$1.01M$2.63M$2.25M$4.25M$5.49M$7.74M$11.52M$18.05M$23.73M$35.51M$60.26M$108.48M$152.91M$253.06M$206.82M$231.31M$214.88M$217.67M
Free cash flow$-12.55M$-8.90M$-8.01M$-13.10M$-14.10M$-29.94M$-44.84M$-48.58M$-93.45M$-156.00M$-144.92M$-140.96M$-220.00M$-284.31M$72.13M$-238.00M$-438.02M$31.93M$74.55M$356.78M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$760000.00$1.72M$2.10M$5.10M$929.78M$17.18M$18.36M$37.51M$169.52M
Share repurchases
Debt repayment
Net change in cash$-42.97M$-22.44M$-494000.00$45.28M$-17.00M$7.79M$28.57M$82.94M$17.10M$1.31B$-1.18B$-73.01M